Perbedaan UBC Medical Indonesia Tbk. dan Unilever Indonesia Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Unilever Indonesia Tbk. diperdagangkan di Rp1.730 (kapitalisasi pasar 67,14 T, volume 24 jam 10 jt). Perbedaan utamanya: Unilever Indonesia Tbk. jauh lebih besar — sekitar 105,6× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Unilever Indonesia Tbk. lebih aktif diperdagangkan (10 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | UNVR | |
|---|---|---|
Kapitalisasi Pasar | 635,95 M | 67,14 T |
Volume | 843 rb | 10 jt |
Lot | 8,43 rb | 99,96 rb |
Perputaran | 137,6 jt | 17,31 M |
Harga Rata-rata | 163,22 | 1.732,16 |
Nilai Transaksi | 137,6 jt | 17,31 M |
Harga Ekuilibrium Indikatif | 165 | 1.730 |
Volume Ekuilibrium Indikatif | 246 | 3,03 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Unilever Indonesia Tbk (the Company) was established on 5 December 1933 as Levers Zeepfabrieken N.V. by deed No. 23 of Mr. A.H. van Ophuijsen, a notary in Batavia, which was approved by the Gouverneur Generaal van Nederlandsch-Indie in letter No. 14 on 16 December 1933, registered at the Raad van Justitie in Batavia under No. 302 on 22 December 1933 and published in the Javasche Courant on 9 January 1934, Supplement No. 3.
Selengkapnya di halaman UNVR →